Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.2.0.727
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Jun. 30, 2015
Jun. 30, 2014
COSTS AND EXPENSES:        
Research and development $ 8,871 $ 4,075 $ 15,700 $ 7,625
General and administrative 2,913 1,974 5,780 3,593
Total operating expenses 11,784 6,049 21,480 11,218
Operating Loss (11,784) (6,049) (21,480) (11,218)
Interest and other financing costs, net 21 5 36 10
NET LOSS $ (11,763) $ (6,044) $ (21,444) $ (11,208)
Net loss per common share, basic and diluted (in dollars per share) $ (0.73) $ (0.61) $ (1.44) $ (1.2)
Weighted average common shares outstanding, basic and diluted (in shares) 16,137,898 9,923,184 14,923,934 9,324,020